CB-3 (CANTABio)

N/A

Report date: 2025/06/11 11:06:07
NME

Base Information

Drug NameCB-3 (CANTABio)
Drug Alias NameDJ1 modulator (CANTABio/Hungarian Academy of Sciences/Melior/Purdue)CB-125 (CANTABio)CB-3 (CANTABio)
ClassificationSmall molecules
Mechanisms of ActionParkinson disease protein 7 modulators
TargetsParkinson disease protein 7
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCantabio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHungarian Academy Of SciencesPurdue UniversityMelior Pharmaceuticals +[4] 
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A